Nutritional Status Is Associated With Clinical Progression in Alzheimer's Disease: The NUDAD Project

被引:23
作者
Doorduijn, Astrid S. [1 ,2 ,9 ]
de van der Schueren, Marian A. E. [3 ,4 ]
van de Rest, Ondine [4 ]
de Leeuw, Francisca A. [2 ,5 ]
Hendriksen, Heleen M. A. [2 ]
Teunissen, Charlotte E. [5 ]
Scheltens, Philip [2 ]
van der Flier, Wiesje M. [2 ,6 ]
Visser, Marjolein [7 ,8 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Nutr & Dietet, Amsterdam UMC, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Alzheimer Ctr Amsterdam, Dept Neurol, Amsterdam Neurosci,Amsterdam UMC, Amsterdam, Netherlands
[3] HAN Univ Appl Sci, Sch Allied Hlth, Dept Nutr & Hlth, Nijmegen, Netherlands
[4] Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands
[5] Vrije Univ Amsterdam, Dept Clin Chem, Neurochem Lab, Amsterdam Neurosci,Amsterdam UMC, Amsterdam, Netherlands
[6] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Amsterdam Neurosci, Amsterdam UMC, Amsterdam, Netherlands
[7] Vrije Univ Amsterdam, Fac Sci, Dept Hlth Sci, Amsterdam, Netherlands
[8] Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands
[9] Amsterdam UMC, Dept Nutr & Dietet, POB 7057, NL-1007 MB Amsterdam, Netherlands
关键词
Malnutrition; food intake; dementia; mild cognitive impairment; subjective cognitive decline; MILD COGNITIVE IMPAIRMENT; BODY-MASS INDEX; WEIGHT-LOSS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; MEDITERRANEAN DIET; DEMENTIA; DECLINE; RECOMMENDATIONS; INTERVENTION;
D O I
10.1016/j.jamda.2020.10.020
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: In cognitively normal adults, nutritional parameters are related to cognitive decline and incidence of dementia. Studies on the role of nutrition in predementia stages subjective cognitive decline and mild cognitive impairment, and mild stages of Alzheimer's disease (AD) dementia in a clinical setting are lacking. In the absence of a curative treatment, this evidence is important for targeting nutritional factors to potentially prevent or delay further cognitive decline. Our aim is to investigate associations of nutritional parameters with clinical progression in patients ranging from those who are cognitively normal to those who have AD dementia.Design: Longitudinal.Setting and Participants: Memory clinic, 551 patients (219 with subjective cognitive decline, 135 with mild cognitive impairment, and 197 with AD dementia), mean age 64 +/- 8 years.Measurements: We assessed body mass index, fat-free mass, Mini-Nutritional Assessment, and dietary intake with the Dutch Healthy Diet food frequency questionnaire and the 238-item healthy life in an urban setting (HELIUS) food frequency questionnaire at baseline. Cox proportional hazard models were used to evaluate associations of nutritional parameters with clinical progression. Additional analyses were restricted to patients who were amyloid positive.Results: We observed clinical progression in 170 patients (31%) over 2.2 +/- 0.9 years. Poorer Mini-Nutritional Assessment score [hazard ratio (95% confidence interval) 1.39 (1.18-1.64)], lower body mass index [1.15 (0.96-1.38)], lower fat-free mass [1.40 (0.93-2.10)], and a less healthy dietary pattern [1.22 (1.01-1.48)] were associated with a higher risk of clinical progression. Similar effect sizes were found in patients who were amyloid positive.Conclusions and Implications: Poorer nutritional status and a less healthy dietary pattern are associated with a higher risk of clinical progression. This study provides support for investigating whether improving nutritional status can alter the clinical trajectory of AD.(c) 2020 The Authors. Published by Elsevier Inc. on behalf of AMDA -The Society for Post-Acute and Long-Term Care Medicine. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:638 / 644.e1
页数:8
相关论文
共 50 条
[41]   Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia [J].
Davis, Matthew ;
O'Connell, Thomas ;
Johnson, Scott ;
Cline, Stephanie ;
Merikle, Elizabeth ;
Martenyi, Ferenc ;
Simpson, Kit .
CURRENT ALZHEIMER RESEARCH, 2018, 15 (08) :777-788
[42]   Mild Cognitive Impairment Progression and Alzheimer's Disease Risk: A Comprehensive Analysis of 3553 Cases over 203 Months [J].
Oksuz, Nevra ;
Ghouri, Reza ;
Tasdelen, Bahar ;
Uluduz, Derya ;
Ozge, Aynur .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
[43]   Transcriptomic predictors of rapid progression from mild cognitive impairment to Alzheimer's disease [J].
Huang, Yi-Long ;
Tsai, Tsung-Hsien ;
Shen, Zhao-Qing ;
Chan, Yun-Hsuan ;
Tu, Chih-Wei ;
Tung, Chien-Yi ;
Wang, Pei-Ning ;
Tsai, Ting-Fen .
ALZHEIMERS RESEARCH & THERAPY, 2025, 17 (01)
[44]   Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease [J].
Tijms, Betty M. ;
ten Kate, Mara ;
Gouw, Alida A. ;
Borta, Andreas ;
Verfaillie, Sander ;
Teunissen, Charlotte E. ;
Scheltens, Philip ;
Barkhof, Frederik ;
van der Flier, Wiesje M. .
NEUROBIOLOGY OF AGING, 2018, 61 :75-81
[45]   Vitamin D in the development and progression of alzheimer's disease: implications for clinical management [J].
Panza, Francesco ;
La Montagna, Maddalena ;
Lampignano, Luisa ;
Zupo, Roberta ;
Bortone, Ilaria ;
Castellana, Fabio ;
Sardone, Rodolfo ;
Borraccino, Luisa ;
Dibello, Vittorio ;
Resta, Emanuela ;
Altamura, Mario ;
Daniele, Antonio ;
Lozupone, Madia .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (03) :287-301
[46]   Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer's disease spectrum [J].
Garcia-Gutierrez, Fernando ;
Alegret, Montserrat ;
Marquie, Marta ;
Munoz, Nathalia ;
Ortega, Gemma ;
Cano, Amanda ;
De Rojas, Itziar ;
Garcia-Gonzalez, Pablo ;
Olive, Claudia ;
Puerta, Raquel ;
Garcia-Sanchez, Ainhoa ;
Capdevila-Bayo, Maria ;
Montrreal, Laura ;
Pytel, Vanesa ;
Rosende-Roca, Maitee ;
Zaldua, Carla ;
Gabirondo, Peru ;
Tarraga, Lluis ;
Ruiz, Agustin ;
Boada, Merce ;
Valero, Sergi .
ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
[47]   Clinical amyloid imaging in Alzheimer's disease [J].
Herholz, Karl ;
Ebmeier, Klaus .
LANCET NEUROLOGY, 2011, 10 (07) :667-670
[48]   A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease [J].
Edwin, Trine Holt ;
Henjum, Kristi ;
Nilsson, Lars N. G. ;
Watne, Leiv Otto ;
Persson, Karin ;
Eldholm, Rannveig Sakshaug ;
Saltvedt, Ingvild ;
Halaas, Nathalie Bodd ;
Selbaek, Geir ;
Engedal, Knut ;
Strand, Bjorn Heine ;
Knapskog, Anne-Brita .
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
[49]   Alzheimer's disease CSF biomarkers: clinical indications and rational use [J].
Niemantsverdriet, Ellis ;
Valckx, Sara ;
Bjerke, Maria ;
Engelborghs, Sebastiaan .
ACTA NEUROLOGICA BELGICA, 2017, 117 (03) :591-602
[50]   Neurophysiological trajectories in Alzheimer's disease progression [J].
Kudo, Kiwamu ;
Ranasinghe, Kamalini G. ;
Morise, Hirofumi ;
Syed, Faatimah ;
Sekihara, Kensuke ;
Rankin, Katherine P. ;
Miller, Bruce L. ;
Kramer, Joel H. ;
Rabinovici, Gil D. ;
Vossel, Keith ;
Kirsch, Heidi E. ;
Nagarajan, Srikantan S. .
ELIFE, 2024, 12